Bio Key International INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OQB
Armistice Capital and Steven Boyd have filed an amended Schedule 13G, disclosing a 4.99% beneficial ownership stake in BIO-KEY International Inc. as of June 30, 2025.
OQB
Streeterville Capital LLC, along with Streeterville Management LLC and John M. Fife, has filed an amended Schedule 13G disclosing a 3.6% beneficial ownership stake in BIO KEY INTERNATIONAL INC.
OQB
Armistice Capital, LLC and Steven Boyd have disclosed a 9.99% passive ownership stake in BIO-key International Inc. through a Schedule 13G filing.
OQB
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting a beneficial ownership of 4.99% in BIO-key International Inc.'s common stock as of December 31, 2024.
OQB
Streeterville Capital LLC, along with Streeterville Management LLC and John M. Fife, has disclosed a beneficial ownership of 9.1% in BIO-key International Inc.'s common stock.